Development and validation of a novel MR imaging predictor of response to induction chemotherapy in locoregionally advanced nasopharyngeal cancer: a randomized controlled trial substudy (NCT01245959)

BACKGROUND: In locoregionally advanced nasopharyngeal carcinoma (LANPC) patients, variance of tumor response to induction chemotherapy (ICT) was observed. We developed and validated a novel imaging biomarker to predict which patients will benefit most from additional ICT compared with chemoradiother...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Di, Zhang, Fan, Zhong, Lian-Zhen, Fang, Meng-Jie, Huang, Cheng-Long, Yao, Ji-Jin, Sun, Ying, Tian, Jie, Ma, Jun, Tang, Ling-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806559/
https://www.ncbi.nlm.nih.gov/pubmed/31640711
http://dx.doi.org/10.1186/s12916-019-1422-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806559/
https://www.ncbi.nlm.nih.gov/pubmed/31640711
http://dx.doi.org/10.1186/s12916-019-1422-6

Ejemplares similares